n/a
Article Publish Status: FREE
Abstract Title:

Effect of-Acetylcysteine Administration on 30-Day Mortality in Critically Ill Patients with Septic Shock Caused by Carbapenem-Resistantand: A Retrospective Case-Control Study.

Abstract Source:

Antibiotics (Basel). 2021 Mar 8 ;10(3). Epub 2021 Mar 8. PMID: 33800296

Abstract Author(s):

Alessandra Oliva, Alessandro Bianchi, Alessandro Russo, Giancarlo Ceccarelli, Francesca Cancelli, Fulvio Aloj, Danilo Alunni Fegatelli, Claudio Maria Mastroianni, Mario Venditti

Article Affiliation:

Alessandra Oliva

Abstract:

Carbapenem-resistant(CR-Kp) and(CR-Ab) represent important cause of severe infections in intensive care unit (ICU) patients.-Acetylcysteine (NAC) is a mucolytic agent with antioxidant and anti-inflammatory properties, showing also in-vitro antibacterial activity. Aim was to evaluate the effect on 30-day mortality of the addition of intravenous NAC to antibiotics in ICU patients with CR-Kp or CR-Ab septic shock. A retrospective, observational case:control study (1:2) in patients with septic shock caused by CR-Kp or CR-Ab hospitalized in two different ICUs was conducted. Cases included patients receiving NAC plus antimicrobials, controls included patients not receiving NAC. Cases and controls were matched for age, SAPS II, causative agent and source of infection. No differences in age, sex, SAPS II score or time to initiate definitive therapy were observed between cases and controls. Pneumonia and bacteremia were the leading infections. Overall, mortality was 48.9% (33.3% vs. 56.7% in cases and controls,= 0.05). Independent risk factors for mortality were not receiving NAC (= 0.002) and CR-Ab (= 0.034) whereas therapy with two in-vitro active antibiotics (= 0.014) and time to initial definite therapy (= 0.026) were protective. NAC plus antibiotics might reduce the 30-day mortality rate in ICU patients with CR-Kp and CR-Ab septic shock.

Study Type : Human Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.